Weight Management Certificate

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

This continuing pharmacy education activity is intended for pharmacists seeking to expand their knowledge and skills in helping patients with weight management.

Learning Activity	ACPE Number	Contact Hours
Introduction to Weight Management and Its Pathophysiology	0204-0000-22-762-H01-P	1.25
Patient-Centered Language and Motivational Interviewing	0204-0000-22-763-H04-P	2.00
Clinical Methodology and Weight-Loss Goals	0204-0000-22-764-H01-P	2.00
Lifestyle Modifications	0204-0000-22-765-H01-P	3.25
Medication-Induced Obesity	0204-0000-22-766-H01-P	1.50
Anti-Obesity Pharmacotherapy, Part 1	0204-0000-22-767-H01-P	2.00
Anti-Obesity Pharmacotherapy, Part 2	0204-0000-22-768-H01-P	2.50
Comorbid Conditions	0204-0000-22-769-H01-P	1.25
Surgical Interventions	0204-0000-22-770-H01-P	1.75
Special Populations	0204-0000-22-771-H01-P	1.50
Interdisciplinary Team Collaborations	0204-0000-22-772-H04-P	1.50
→  Final Assessment: (80% passing score required)

Introduction to Weight Management and Its Pathophysiology
0204-0000-22-762-H01-P

• Summarize weight management trends for obesity prevalence and predicted prevalence for 2030.
• Apply weight and obesity-related definitions.
• Assess the economic burden of obesity and weight issues.
• Summarize the pathophysiology of obesity.

Patient-Centered Language and Motivational Interviewing
0204-0000-22-763-H04-P

• Identify examples of person-centered and strengths-based language for use in person-centered communication.
• Use patient-centered language.
• Employ the purpose, fundamental principles, and skills of motivational interviewing in strengths-based weight management conversations.
• Apply the principles and skills of motivational interviewing in person-centered communication.

Clinical Methodology and Weight-Loss Goals
0204-0000-22-764-H01-P

• Recommend an appropriate weight loss strategy.
• Use a person-centered, clinical approach (e.g., the 5As of Obesity Management) for weight management.
• Differentiate the staging of body weight according to national guidelines.
• Evaluate assessment tools and methods for weight management.
• Summarize the challenges associated with the use of assessment tools for weight management.
• Apply evidence-based guidelines on weight-loss goals to individuals with weight issues or obesity.
• Develop individualized weight-loss goals for different types of patient scenarios.

Lifestyle Modifications
0204-0000-22-765-H01-P

• Recommend patient-specific nutrition and lifestyle modifications for weight management based on national-level guidelines.
• Determine appropriate energy needs for patients based on gender, age, physical activity level, and special circumstances.
• Compare dietary patterns for weight management.
• Define the exercise, physical activity, and sedentary behavior recommended guidelines.
• Identify the principles of exercise behavior and the FITT principle.
• Assess different types of exercise and components of an exercise routine.
• Apply exercise concepts and strategies to weight management exercise prescriptions including contraindications for exercise.
• Differentiate between evidence-based behavioralweight loss programs.
• Summarize evidence-based behavioral strategies for weight loss, including the use of mobile apps.
• Identify psychological and medical comorbidities that interfere with weight loss.

Medication-Induced Obesity
0204-0000-22-766-H01-P

• Assess the effect of specific medications for treating other medical conditions on weight management.
• Compare treatment regimens for certain disease states to minimize medication induced weight gain.
• Given a patient case, develop a plan to promote weight loss.

Anti-Obesity Pharmacotherapy, Part 1
0204-0000-22-767-H01-P

• Describe guidance from the Food and Drug Administration for weight management.
• Differentiate treatment recommendations for pharmacological options in weight management.
• Differentiate treatment recommendations for weight management.
• Assess drug therapy efficacy and safety through evidence-based medicine.
• Recommend drug therapy for specific patient case scenarios.

Anti-Obesity Pharmacotherapy, Part 2
0204-0000-22-768-H01-P

• Categorize differences of FDA and non-FDA approved medications for facilitating weight loss.
• Analyze evidence related to investigational and off-label therapy use in weight loss and management.
• Given a patient case, assess investigational and off-label drug therapy use for weight management.
• Analyze evidence related to alternative therapy use in weight loss and management.
• Counsel on safety and efficacy of alternative therapies used in weight loss and weight management.
• Analyze evidence related to alternative therapy use in weight loss and management.
• Counsel on safety and efficacy of alternative therapies used in weight loss and weight management.

Comorbid Conditions
0204-0000-22-769-H01-P

• Assess comorbid conditions and challenges that arise from being overweight or obese.
• Identify specific risk factors for developing unique comorbid conditions.
• Compare strategies to lessen the risk of developing comorbid conditions.
• Design a plan for a patient presenting with obesity and comorbid conditions.

Surgical Interventions
0204-0000-22-770-H01-P

• Apply guideline recommendations for obesity-related surgical interventions.
• Plan pre-surgical care for patients.
• Differentiate between types of surgical interventions for weight management.
• Apply knowledge of weight management surgical interventions to the management of medications in post-operative patients.
• Manage nutritional deficiencies in patients after weight management surgery.

Special Populations
0204-0000-22-771-H01-P

• Apply weight loss treatment guidelines to pregnant or pediatric patients.
• Evaluate lifestyle modifications, pharmacotherapy interventions, and surgical interventions for pregnant or pediatric patients.
• Given a patient case, design an evidence-based weight loss treatment regimen for a pregnant patient.
• Assess complications of obesity within special populations.
• Apply lifestyle modifications, pharmacotherapy, interventions, and surgical interventions for special populations.     
• Design a treatment plan for weight loss for a person within a special population.

Interdisciplinary Team Collaborations
0204-0000-22-772-H04-P

• Analyze how the core elements of the Chronic Care Model support optimization of chronic diseases.
• Assess how pharmacists may contribute to a Chronic Care Model.
• Develop a plan for onboarding c-suite and health-system leadership for a weight management program.
• Evaluate the role of a pharmacist for weight management in variety of clinical settings.
• Apply strategies for measuring success and continuous quality improvements in a weight management program.

Nicole P. Albanese, Pharm.D., BCACP CDCES
Clinical Associate Professor
University at Buffalo
Residency Program Director
Buffalo Medical Group
Buffalo, New York

Jennifer Clements, Pharm.D., BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP
Clinical Pharmacist - Diabetes Transition
Spartanburg Regional Healthcare System
Spartanburg, South Carolina

Katie D. Ellis, Pharm.D., AE-C, BCPPS
Assistant Professor of Pharmacy Practice
Presbyterian College School of Pharmacy
Clinton, South Carolina

Kristen Hicks-Roof, Ph.D., RDN, LDN, CLC, FAND
Assistant Professor
University of North Florida
Jacksonville, Florida

Cassandra Hobbs, Pharm.D., M.B.A., BCACP, LDE
Associate Professor
Sullivan University College of Pharmacy and Health Sciences
Louisville, Kentucky

Jan Kavookjian, Ph.D., M.B.A., FAPhA, FADCES
Associate Professor, Health Outcomes Research & Policy
Auburn University Harrison School of Pharmacy
Auburn, Alabama

Emily McCoy, Pharm.D., BCACP
Associate Clinical Professor
Auburn University Harrison School of Pharmacy
Adjunct Assistant Professor
Department of Internal Medicine
University of South Alabama College of Medicine
Mobile, Alabama

Anne Misher, Pharm.D., M.B.A., BCACP, BC-ADM, CDCES
Patient Health Support Pharmacist
CaroMont Health
Gastonia, North Carolina

Katherine O'Neal, Pharm.D, M.B.A., AE-C, BCACP, BC-ADM, CDCES, CLS, FADCES
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma

Sherry Pagoto, Ph.D.
Professor and Licensed Clinical Psychologist
University of Connecticut
Storrs, Connecticut

April Miller Quidley, Pharm.D., BCCCP, BCPS, FCCM, FCCP
Supervisor, Critical Care and Emergency Medicine
Vidant Medical Center
Greenville, North Carolina

Sara Reece, Pharm.D., BCACP, BC-ADM, CDCES, FADCES
Associate Professor and Vice Chair, Pharmacy Practice, and Director of IPE SOP
Philadelphia College of Osteopathic Medicine Georgia Campus School of Pharmacy
Suwanee, Georgia
Ambulatory Care Pharmacist and Core Faculty
Northeast Georgia Medical Center Family Medicine GME Program
Gainesville, Georgia

Daniel M. Riche, Pharm.D., FCCP, CLS, ASH-CHC
Professor
University of Mississippi School of Pharmacy
University, Mississippi

Pamela L. Stamm, Pharm.D., BCACP, BCPS, CDCES, FASHP
Associate Professor of Pharmacy Practice
Auburn University
Auburn, Alabama
Clinical Pharmacist Specialist
Central Alabama VA Healthcare Center, Community Based Outpatient Clinic
Fort Benning, Georgia

Danielle Wadsworth, Ph.D.
Associate Professor
Auburn University
Auburn, Alabama

Heather P. Whitley, Pharm.D., BCPS, CDCES
Clinical Professor
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Clinical Pharmacy Specialist
Baptist Family Medicine, Baptist Health System
Montgomery, Alabama

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

The following persons in control of this activity’s content have relevant financial relationships:

Jennifer Clements

• Novo Nordisk: speakers bureau, advisory board

Cassandra Hobbs

• Sullivan University, research grant

Jan Kavookjian

• Merck: speakers bureau (motivational interviewing)
• MediMergent, LLC: consultant (pharmacist motivational interviewing training)

Sherry Pagoto

• WW (formerly Weight Watchers^©): principal investigator
• Fitbit^©: scientific advisor

All other persons in control of content do not have any relevant financial relationships with an ineligible company.

As required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.

This online activity consists of a combined total of 11 learning modules. Pharmacists are eligible to receive a total of 20.5 hours of continuing education credit by completing all 11 modules within this certificate.

Participants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.